JP-1730 to Treat Parkinson's Disease
NCT00040209
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
NIH
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
JP 1730
DRUG:
IV Levodopa
DRUG:
IV Apomorphine
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)